Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +2.32% rallied 1.83% to $174.27 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +2.27% rising 2.89% to 12,854.80 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.66% rising 1.63% to 33,309.51. The stock's rise snapped a three-day losing streak. Moderna Inc. closed $290.58 below its 52-week high ($464.85), which the company achieved on September 10th.
The stock outperformed some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +3.06% rose 0.49% to $140.94, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +2.24% rose 1.50% to $252.09, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.29% rose 0.62% to $66.30. Trading volume (3.5 M) remained 1.7 million below its 50-day average volume of 5.2 M.